Skip to main content
. 2017 Feb 23;8(2):e2627. doi: 10.1038/cddis.2017.51

Figure 6.

Figure 6

(a) BCL10 inhibitory peptide represses NF-κB signaling upon PAMPs recognition in NHEK. NHEK were liposome-delivered with a BCL10 inhibitory peptide (i-BCL10) or a control scrambled peptide (c-BCL10) and exposed to PAMPs for 24 h. Expression level of the indicated NF-κB responsive genes was determined by real-time PCR. Data shown are representative of six independent experiments done in triplicate. Right panel: FITC-conjugated i-BCL10 peptide was used to monitor delivery efficiency (≅50%). (b) The expression levels of BCL10, MALT1 and CARMA2sh in NHEK left untreated or i-BCL10-delivered were assessed by western blot